Middle East & Africa Antiviral Drugs Market to 2032
Overview
The Middle East & Africa Antiviral Drugs Market is expected to reach a 2.36 USD Billion by 2032 and is projected to grow at a CAGR of 4.17% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.87
Forecast, 2032 (USD Billion)
2.36
CAGR, 2024 - 2032
4.17%
Report Coverage
Middle East & Africa
Middle East & Africa Antiviral Drugs Market 2018-2032 USD Billion
Middle East & Africa Antiviral Drugs Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.87 USD Billion
- Projected Market Size (2032): 2.36 USD Billion
- CAGR (2025-2032): 4.17%
Key Findings of Middle East & Africa Antiviral Drugs Market
- The Middle East & Africa Antiviral Drugs Market was valued at 1.87 USD Billion in 2024.
- The Middle East & Africa Antiviral Drugs Market is likely to grow at a CAGR of 4.17% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Topical in Products Segment accounted for the largest share of the market with a revenue of 1.87 USD Billion
- The fastest growing segment Influenza in Indication Segment grew Fastest with a CAGR of 4.79% during the forecast period from 2024 to 2032.
Middle East & Africa Antiviral Drugs Market Scope
Middle East & Africa Antiviral Drugs Market Segmentation & Scope
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Products
- Parenteral
- Oral
- Topical
Patient
- Geriatric
- Child
- Adult
Drug
- Branded
- Generic
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Middle East & Africa Antiviral Drugs Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.87 USD Billion |
| Market Value in 2032 | 2.36 USD Billion |
| CAGR (2025-2032) | 4.17% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication,Products,Patient,Drug,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 1.87 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 693.69 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Antiviral Drugs Market to 2032, By Indication
- Influenza is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.16 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.79 % in forecast period 2025-2032.
-
Middle East & Africa Antiviral Drugs Market to 2032, By Products
- Topical is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.87 USD Billion in the year 2024.
- Oral is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.17 % in forecast period 2025-2032.
-
Middle East & Africa Antiviral Drugs Market to 2032, By Patient
- Geriatric is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.32 USD Billion in the year 2024.
- Geriatric is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.71 % in forecast period 2025-2032.
-
Middle East & Africa Antiviral Drugs Market to 2032, By Drug
- Generic is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.49 USD Billion in the year 2024.
- Generic is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.33 % in forecast period 2025-2032.
-
Middle East & Africa Antiviral Drugs Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.35 USD Billion in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.69 % in forecast period 2025-2032.
-
Middle East & Africa Antiviral Drugs Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Middle East & Africa Antiviral Drugs Market to 2032 with a revenue of 1.37 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Middle East & Africa Antiviral Drugs Market to 2032 with a Growth rate of 4.60 % in forecast period 2025-2032.
Middle East & Africa Antiviral Drugs Market Company Share Analysis
| Company Name |
|
||
| Teva Pharmaceutical Industries Ltd. | |||
| Pfizer Inc. | |||
| Gilead Sciences, Inc. | |||
| GSK plc. | |||
| F. Hoffmann-La Roche Ltd. | |||
Middle East & Africa Antiviral Drugs Market Geographical Sales Distribution, 2018-2032 USD Billion
Middle East & Africa Antiviral Drugs Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Patient,Drug,End User,Distribution Channel.
Middle East & Africa Antiviral Drugs Market was valued at USD 1.87(Revenue in USD Billion) in 2021.
Middle East & Africa Antiviral Drugs Market is projected to grow at a CAGR of 4.17% during the forecast period of 2024 to 2032.
The Topical segment is expected to dominate the Middle East & Africa Antiviral Drugs Market, holding a largest market share of 1.87 USD Billion in 2024
Middle East & Africa Antiviral Drugs Market Scope
Middle East & Africa Antiviral Drugs Market Segmentation & Scope
Indication
- Others
- Coronavirus Infection
- Respiratory Syncytial Virus
- Hepatitis B Virus
- Varicella-Zoster Virus (VZV)
- Human Cytomegalovirus (HCMV)
- Herpes Simplex Virus
- Hepatitis C Virus
- Human Immunodeficiency Virus (HIV)
- Influenza
Products
- Parenteral
- Oral
- Topical
Patient
- Geriatric
- Child
- Adult
Drug
- Branded
- Generic
End User
- Others
- Home Healthcare
- Clinics
- Ambultatory Centres
- Speciality Centers
- Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Frequently Asked Questions
The Middle East & Africa Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Patient,Drug,End User,Distribution Channel.
Middle East & Africa Antiviral Drugs Market was valued at USD 1.87(Revenue in USD Billion) in 2021.
Middle East & Africa Antiviral Drugs Market is projected to grow at a CAGR of 4.17% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Antiviral Drugs Market for final year is USD 2.36 (USD Billion).
Middle East & Africa Antiviral Drugs Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Antiviral Drugs Market is segmented based on Segmentation Indication,Products,Patient,Drug,End User,Distribution Channel.
Middle East & Africa Antiviral Drugs Market was valued at USD 1.87(Revenue in USD Billion) in 2021.
Middle East & Africa Antiviral Drugs Market is projected to grow at a CAGR of 4.17% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Antiviral Drugs Market for final year is USD 2.36 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.